Hypernatremia Detected
Serum Na >145 mmol/L
All Pathways
EndocrinologyEmergency
Severe Hypernatremia Management
Severe Hypernatremia Management: Hypernatremia Detected → Assess Severity → Clinical Manifestations → Assess Volume Status → Hypovolemic Hypernatremia.
Pathway Overview
14 steps
Algorithm Steps
14 total
01Start 02Decision Assess Severity
Classify hypernatremia
- Mild: 146-150 mmol/L
- Moderate: 151-159 mmol/L
- Severe: ≥160 mmol/L
- Also assess acuity: Acute (<48h) vs Chronic (≥48h)
03Action Clinical Manifestations
Neurologic symptoms predominate
- Lethargy, weakness, irritability
- Altered mental status, confusion
- Hyperreflexia, spasticity
- Seizures (usually in acute cases)
- Coma (severe hypernatremia)
- Signs of volume depletion if hypovolemic
04Decision Assess Volume Status
Guides initial fluid choice
- HYPOVOLEMIC: Tachycardia, hypotension, dry mucosa, poor skin turgor
- EUVOLEMIC: Normal vitals, often pure water loss
- HYPERVOLEMIC: Edema, hypertension (iatrogenic Na loading)
05Action Hypovolemic Hypernatremia
Lost water > sodium
- Causes: GI losses, osmotic diuresis, burns, fever
- Step 1: Volume resuscitate with 0.9% NS first
- Step 2: Once stable, switch to 0.45% NS or D5W
- Replace volume deficit + ongoing losses
06Action Calculate Free Water Deficit
Guide replacement volume
- Formula: FWD = TBW × [(Serum Na / 140) - 1]
- TBW = Weight (kg) × 0.6 (men) or 0.5 (women)
- Example: 70kg male, Na=160: TBW=42L, FWD=42×(160/140-1)=6L
- Replace deficit + ongoing losses over 48-72 hours
07Warning ⚠️ Correction Rate - CRITICAL
Avoid cerebral edema from rapid correction
- ACUTE (<48h): Can correct 1-2 mmol/L/hr, normalize within 24h
- CHRONIC (≥48h): MUST correct slowly
- Target: ≤0.5 mmol/L/hr or 8-10 mmol/L/24h maximum
- Brain adapts to chronic hypernatremia with organic osmolytes
- Rapid correction → water shifts into brain → cerebral edema
- Too slow (<0.25 mmol/L/hr, <6 mmol/L/day) also increases mortality
08Action Fluid Selection
Choose appropriate replacement
- D5W: Most hypotonic, for pure water deficit
- 0.45% NS: Half normal saline, moderate hypotonicity
- 0.9% NS: For initial resuscitation in hypovolemic patients
- Oral water: If patient can drink safely
- Rate depends on deficit size and target correction
09Action Monitoring
Close follow-up during correction
- Serum Na: q2-4h during active treatment
- Urine output and specific gravity
- Neurologic status
- Adjust infusion rate based on response
- Account for ongoing losses
10Action Treat Underlying Cause
Prevent recurrence
- Central DI: Desmopressin intranasal/IV
- Nephrogenic DI: Thiazides, NSAIDs, low Na diet
- Osmotic diuresis: Control glucose/urea
- Access to water: Ensure adequate intake
11Outcome Safe Correction Achieved
Na normalized, symptoms improved
12Warning ICU Admission
Severe (Na≥160) or symptomatic cases
13Action Euvolemic Hypernatremia
Pure water loss
- Causes: Diabetes insipidus (central or nephrogenic), insensible losses
- Treatment: Free water replacement
- D5W or 0.45% NS IV
- If DI: Desmopressin for central DI, thiazides for nephrogenic DI
- Path rejoins step 06Shared downstream outcome
14Action Hypervolemic Hypernatremia
Sodium excess
- Causes: Hypertonic saline, NaHCO3, salt tablets, mineralocorticoid excess
- Treatment: D5W + Loop diuretics
- Remove sodium while replacing water
- Consider dialysis if severe
- Path rejoins step 06Shared downstream outcome
Guideline Source
Hypernatremia Management: Expert Consensus and Systematic Reviews 2025
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Optimal correction rate remains debated in literature
- Does not address neonatal hypernatremia
- Underlying cause determines long-term management
- Central DI management has specific considerations
Applicable Regions
USEU
EU: Society for Endocrinology guidance applies
US: Based on expert consensus and recent evidence
Version 1Next review: 2027-01-01
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Severe Hypernatremia Management?
The Severe Hypernatremia Management is a emergency clinical algorithm for Endocrinology. It provides a structured decision tree to guide clinical decision-making, based on Hypernatremia Management: Expert Consensus and Systematic Reviews 2025.
What guideline is the Severe Hypernatremia Management based on?
This algorithm is based on Hypernatremia Management: Expert Consensus and Systematic Reviews 2025 (DOI: 10.34067/KID.0000000785).
What are the limitations of the Severe Hypernatremia Management?
Known limitations include: Optimal correction rate remains debated in literature; Does not address neonatal hypernatremia; Underlying cause determines long-term management; Central DI management has specific considerations. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Severe Hypernatremia Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free